Previously, it was thought that the COVID-19 vaccination would reduce the
efficacy of medications used to treat nasopharyngeal cancer. However, a new
study demonstrates that the contrary is true; the vaccine actually aids in
treating this type of throat cancer.
efficacy of medications used to treat nasopharyngeal cancer. However, a new
study demonstrates that the contrary is true; the vaccine actually aids in
treating this type of throat cancer.
Anti-PD-1 therapy, a form of immunotherapy commonly used to treat
nasopharyngeal cancer, works by blocking PD-1 receptors on the surfaces of
immune cells that are usually responsible for hunting down intruders.
Cancer cells hijack these receptors to inhibit the body’s natural defenses
against tumors, but blocking them frees immune cells to do their business.
